Best Hospitals for Medical Oncology in India

• Chemotherapy27 validated hospitals
• Immunotherapy27 validated hospitals
• Targeted Therapy27 validated hospitals
• Hormone Therapy15 validated hospitals
• Molecular Targeted Therapy2 validated hospitals
• Neoadjuvant Chemotherapy3 validated hospitals
• Adjuvant Chemotherapy3 validated hospitals
• Palliative Chemotherapy3 validated hospitals
• CAR-T Cell Therapy7 validated hospitals
• Bone Marrow Transplantation2 validated hospitals
• Stem Cell Transplantation3 validated hospitals

• Bengaluru2 validated hospitals
• Chennai4 validated hospitals
• Delhi NCR14 validated hospitals
• Hyderabad5 validated hospitals
• Mumbai4 validated hospitals

• Chemotherapy treatment guide

  Chemotherapy uses cytotoxic medicines that damage rapidly dividing cancer cells and may be given by infusion, injection or tablets in repeating treatment-and-recovery cycles. An infusion regimen is prepared by oncology pharmacy and given in day-care over minutes or hours; some regimens use oral or injected medicines. Each cycle includes treatment days and a recovery interval.

• Immunotherapy treatment guide

  Cancer immunotherapy uses medicines or cellular approaches intended to help the immune system recognise or attack cancer; checkpoint inhibitors are the commonest systemic example in routine solid-tumour care. Most checkpoint medicines are intravenous infusions repeated every few weeks; schedules differ by drug and indication. Cellular or vaccine approaches are separate products and should not be hidden under a generic immunotherapy quote.

• Targeted Therapy treatment guide

  Targeted therapy uses a medicine aimed at a molecular alteration, receptor or signalling pathway that matters to a particular cancer rather than treating all cancers as biologically alike. Some targeted medicines are tablets taken daily; others are injections or infusions on repeating schedules. Oral treatment still needs prescribing, interaction checks, toxicity monitoring and reliable supply.

• Hormone Therapy treatment guide

  Hormone therapy, also called endocrine therapy, blocks hormone production or receptor signalling in cancers that depend on hormones, particularly selected breast and prostate cancers. Treatment may be a daily tablet, periodic injection, or a combination. Long duration makes continuity, adherence and management of chronic effects more important than one clinic visit.

• Molecular Targeted Therapy treatment guide

  Molecular targeted therapy uses a medicine selected for a documented mutation, fusion, amplification or other tumour-driving alteration. Many molecular inhibitors are oral daily medicines; some matched antibodies or other agents are infused. Each has medicine-specific dosing, interaction and monitoring rules.

• Neoadjuvant Chemotherapy treatment guide

  Neoadjuvant chemotherapy is systemic treatment given before a planned operation, often to shrink disease, treat microscopic spread early or show how the tumour responds. Treatment uses regimen-specific day-care or oral cycles before surgery. Imaging or examination after defined cycles decides whether surgery proceeds, changes or is deferred.

• Adjuvant Chemotherapy treatment guide

  Adjuvant chemotherapy is systemic treatment given after an operation to lower the risk from microscopic cancer cells that surgery and scans cannot show. Regimen-specific cycles begin after adequate surgical recovery and are usually delivered in infusion day-care, sometimes with oral medicines.

• Palliative Chemotherapy treatment guide

  Palliative chemotherapy uses anticancer medicines when the stated goal is disease control, symptom relief or longer life rather than cure. Lower-intensity or standard regimen-specific cycles may be infused or taken orally. Treatment continues only while benefit and tolerance justify the burden.

• CAR-T Cell Therapy treatment guide

  CAR-T cell therapy collects a patient's T cells, genetically engineers them to recognise a cancer target, expands them, then returns them after lymphodepleting treatment. The pathway includes apheresis, off-site or on-site manufacturing, possible bridging therapy, lymphodepletion, a single cell infusion and close post-infusion monitoring.

• Bone Marrow Transplantation treatment guide

  Bone marrow transplantation is haematopoietic stem-cell transplantation using a planned graft after conditioning; despite the familiar name, graft cells may come from marrow, peripheral blood or cord blood. After donor or collection work-up, conditioning is given, stem cells are infused, and the patient remains under close inpatient or unit-based monitoring through early engraftment.

• Stem Cell Transplantation treatment guide

  Stem cell transplantation, or haematopoietic cell transplantation, restores blood-forming cells after conditioning using the patient's own collected cells or a donor graft. Cells are collected or sourced from a donor, conditioning is delivered, the graft is infused, and the patient is monitored through marrow suppression and early engraftment.

• Chemotherapy cost in India

  $1,500–$8,000+ indicative planning range

• Immunotherapy cost in India

  $15,000–$45,000 indicative planning range

• Targeted Therapy cost in India

  $8,000–$30,000 indicative planning range

• Hormone Therapy cost in India

  $1,000–$4,500 indicative planning range

• Molecular Targeted Therapy cost in India

  $10,000–$32,000 indicative planning range

• Neoadjuvant Chemotherapy cost in India

  $2,500–$10,000 indicative planning range

• Adjuvant Chemotherapy cost in India

  $2,500–$10,000 indicative planning range

• Palliative Chemotherapy cost in India

  $1,500–$7,000 indicative planning range

• CAR-T Cell Therapy cost in India

  $80,000–$180,000 indicative planning range

• Bone Marrow Transplantation cost in India

  $25,000–$70,000 indicative planning range

• Stem Cell Transplantation cost in India

  $22,000–$65,000 indicative planning range

India planning ranges are not city tariffs, hospital quotations or patient-specific prices. A named hospital must confirm the written estimate.